Regulus Therapeutics
RGLS
#8761
Rank
S$0.13 B
Marketcap
$2.09
Share price
10.64%
Change (1 day)
13.71%
Change (1 year)

Regulus Therapeutics (RGLS) - P/B ratio

P/B ratio as of November 2024 : 1.04

According to Regulus Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Regulus Therapeutics - P/B ratio (from 2012 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-311.2276.29%
2022-12-310.6930-17.17%
2021-12-310.8367-74.6%
2020-12-313.29252.45%
2019-12-310.9346-166.67%
2018-12-31-1.40-145.66%
2017-12-313.0744.57%
2016-12-312.12-42.63%
2015-12-313.70-37.76%
2014-12-315.9579.97%
2013-12-313.30-9.11%
2012-12-313.64
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
4.09 292.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.64 57.82%๐Ÿ‡ซ๐Ÿ‡ท France
1.50 44.03%๐Ÿ‡บ๐Ÿ‡ธ USA
5.10 390.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
> 1000 102,921.92%๐Ÿ‡บ๐Ÿ‡ธ USA
23.8 2,188.71%๐Ÿ‡บ๐Ÿ‡ธ USA
6.96 568.71%๐Ÿ‡บ๐Ÿ‡ธ USA